BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 38181574)

  • 1. Protein-based nanoparticles for therapeutic nucleic acid delivery.
    Eweje F; Walsh ML; Ahmad K; Ibrahim V; Alrefai A; Chen J; Chaikof EL
    Biomaterials; 2024 Mar; 305():122464. PubMed ID: 38181574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical modifications of nucleic acid drugs and their delivery systems for gene-based therapy.
    Chen C; Yang Z; Tang X
    Med Res Rev; 2018 May; 38(3):829-869. PubMed ID: 29315675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical review of nucleic acid nanotechnology to identify gaps and inform a strategy for accelerated clinical translation.
    Afonin KA; Dobrovolskaia MA; Ke W; Grodzinski P; Bathe M
    Adv Drug Deliv Rev; 2022 Feb; 181():114081. PubMed ID: 34915069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid-based nucleic acid therapeutics with in vivo efficacy.
    Sufian MA; Ilies MA
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023 Mar; 15(2):e1856. PubMed ID: 36180107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spherical Nucleic Acid Nanoparticles: Therapeutic Potential.
    Kapadia CH; Melamed JR; Day ES
    BioDrugs; 2018 Aug; 32(4):297-309. PubMed ID: 29959665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer-Targeting Nanoparticles for Combinatorial Nucleic Acid Delivery.
    Vaughan HJ; Green JJ; Tzeng SY
    Adv Mater; 2020 Apr; 32(13):e1901081. PubMed ID: 31222852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptides for nucleic acid delivery.
    Lehto T; Ezzat K; Wood MJA; El Andaloussi S
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):172-182. PubMed ID: 27349594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent insights into the development of nucleic acid-based nanoparticles for tumor-targeted drug delivery.
    Buddolla AL; Kim S
    Colloids Surf B Biointerfaces; 2018 Dec; 172():315-322. PubMed ID: 30176511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioengineered nanotechnology for nucleic acid delivery.
    Zhang Y; Luo J; Gui X; Zheng Y; Schaar E; Liu G; Shi J
    J Control Release; 2023 Dec; 364():124-141. PubMed ID: 37879440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide-Assisted Nucleic Acid Delivery Systems on the Rise.
    Tarvirdipour S; Skowicki M; Schoenenberger CA; Palivan CG
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gold nanoparticles for nucleic acid delivery.
    Ding Y; Jiang Z; Saha K; Kim CS; Kim ST; Landis RF; Rotello VM
    Mol Ther; 2014 Jun; 22(6):1075-1083. PubMed ID: 24599278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineered Silica Nanoparticles for Nucleic Acid Delivery.
    Zhang Y; Yu Y; Yang Y; Wang Y; Yu C
    Small Methods; 2024 Mar; 8(3):e2300812. PubMed ID: 37906035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent applications of the combination of mesoporous silica nanoparticles with nucleic acids: development of bioresponsive devices, carriers and sensors.
    Castillo RR; Baeza A; Vallet-RegĂ­ M
    Biomater Sci; 2017 Feb; 5(3):353-377. PubMed ID: 28105473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyester-based nanoparticles for nucleic acid delivery.
    Zhao J; Weng G; Li J; Zhu J; Zhao J
    Mater Sci Eng C Mater Biol Appl; 2018 Nov; 92():983-994. PubMed ID: 30184828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poly (beta-amino ester) as an in vivo nanocarrier for therapeutic nucleic acids.
    Sadeqi Nezhad M
    Biotechnol Bioeng; 2023 Jan; 120(1):95-113. PubMed ID: 36266918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comprehensive review of cancer therapies mediated by conjugated gold nanoparticles with nucleic acid.
    Hosseini SA; Kardani A; Yaghoobi H
    Int J Biol Macromol; 2023 Dec; 253(Pt 5):127184. PubMed ID: 37797860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applications of Spherical Nucleic Acid Nanoparticles as Delivery Systems.
    Mokhtarzadeh A; Vahidnezhad H; Youssefian L; Mosafer J; Baradaran B; Uitto J
    Trends Mol Med; 2019 Dec; 25(12):1066-1079. PubMed ID: 31703931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redox-Responsive Polymeric Nanoparticle for Nucleic Acid Delivery and Cancer Therapy: Progress, Opportunities, and Challenges.
    Xu L; Cao Y; Xu Y; Li R; Xu X
    Macromol Biosci; 2024 Mar; 24(3):e2300238. PubMed ID: 37573033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of "CLAN" Nanomedicine for Nucleic Acid Therapeutics.
    Xu CF; Iqbal S; Shen S; Luo YL; Yang X; Wang J
    Small; 2019 Apr; 15(16):e1900055. PubMed ID: 30884095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticles for vaccine and gene therapy: Overcoming the barriers to nucleic acid delivery.
    Mollé LM; Smyth CH; Yuen D; Johnston APR
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Nov; 14(6):e1809. PubMed ID: 36416028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.